CLARITIN HIVES RELIEF REDITAB Drug Patent Profile
✉ Email this page to a colleague
When do Claritin Hives Relief Reditab patents expire, and when can generic versions of Claritin Hives Relief Reditab launch?
Claritin Hives Relief Reditab is a drug marketed by Bayer Healthcare Llc and is included in one NDA.
The generic ingredient in CLARITIN HIVES RELIEF REDITAB is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and fifty-five suppliers are listed for this compound. Additional details are available on the loratadine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Claritin Hives Relief Reditab
A generic version of CLARITIN HIVES RELIEF REDITAB was approved as loratadine by PLD ACQUISITIONS LLC on January 21st, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLARITIN HIVES RELIEF REDITAB?
- What are the global sales for CLARITIN HIVES RELIEF REDITAB?
- What is Average Wholesale Price for CLARITIN HIVES RELIEF REDITAB?
Summary for CLARITIN HIVES RELIEF REDITAB
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 148 |
Patent Applications: | 3,951 |
DailyMed Link: | CLARITIN HIVES RELIEF REDITAB at DailyMed |
US Patents and Regulatory Information for CLARITIN HIVES RELIEF REDITAB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Healthcare Llc | CLARITIN HIVES RELIEF REDITAB | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 020704-003 | Nov 19, 2003 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CLARITIN HIVES RELIEF REDITAB
See the table below for patents covering CLARITIN HIVES RELIEF REDITAB around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2882577 | ⤷ Sign Up | |
Australia | 570306 | ⤷ Sign Up | |
Kenya | 3171 | PHARMACEUTICAL DOSAGE FORMS | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CLARITIN HIVES RELIEF REDITAB
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1110543 | 08C0004 | France | ⤷ Sign Up | PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730 |
0152897 | 2001C/013 | Belgium | ⤷ Sign Up | PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115 |
0152897 | SPC/GB01/012 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |